Company intelligence / Profile preview

i2020 Accelerator

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

i2020 Accelerator does not appear to run its own clinical trials; it co-creates and advances multiple discovery-stage programs with partner companies toward advanced lead and clinical candidate selection within about two years.

Modalities: Small molecule
Industry: Drug Discovery Services

Partnerships

Torrey Pines InvestmentOrbiMed AdvisorsMolsoft LLCPortfolio/co-created companies including Ogwen Therapeutics, Llydaw Therapeutics, Mwyngil Therapeutics, Trawsfynydd Therapeutics, Gwynant Therapeutics, Celyn Therapeutics, Loch Lomond Therapeutics, Loch Eil Therapeutics, Loch Ness Therapeutics and Llyn Bala Therapeutics.

Beyond the preview

Go deeper on i2020 Accelerator.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on i2020 Accelerator.

Explore the full profile